T1	Participants 79 135	rheumatic arthropathies (inflammatory and degenerative)]
T2	Participants 261 339	patients suffering from inflammatory and degenerative rheumatic arthropathies.
T3	Participants 369 531	30 subjects using the controlled experiment technique according to the "between patient" pattern, attributing parsalmide and indomethacin at random to two groups.
